Article
Immune checkpoint markers and tumour mutation burden in Wilms tumour: a study of 59 cases.
Pathology - 1 Oct 2024
Mattis Aidas J, Chen Jie-Fu, Gonzalez Ivan A, Rais Rehan, Dehner Louis P, Pfeifer John, He Mai
Abstract excerpt
Wilms tumour (WT) is the most common renal tumour in children, and studies of immune checkpoint inhibitors (ICIs) treatment and markers are limited in number. In this study we investigated the ICIs' related immune landscape by examining the expression of PD-L1, PD-1, CD8 and DNA mismatch repair (MMR) proteins by immunohistochemistry (IHC), tumour mutation burden (TMB), and correlations with histology and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
